ORAOV1 antibody (AA 31-137)
Quick Overview for ORAOV1 antibody (AA 31-137) (ABIN2178087)
Target
Reactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 31-137
-
Predicted Reactivity
- Human,Mouse,Rat,Dog,Cow,Pig,Horse
-
Purification
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human ORAV1 (31-75aa)
-
Isotype
- IgG
-
-
-
-
Application Notes
-
WB 1:300-5000
ELISA 1:500-1000
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
-
Expiry Date
- 12 months
-
-
- ORAOV1 (Oral Cancer Overexpressed 1 (ORAOV1))
-
Alternative Name
- ORAV1
-
Background
-
Synonyms: Oral cancer overexpressed 1, Oral cancer overexpressed protein 1 A, ORAOV1 oral cancer overexpressed 1, TAOS1, Tumor amplified and overexpressed sequence 1, ORAV1_HUMAN.
Background: ORAV1
Target
-